StonvexLoading…
StonvexStonvexStonvexCore line items from TENB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $999.40M | $900.02M | $798.71M | $683.19M |
Operating Income | $-9.17M | $-6.86M | $-52.16M | $-67.81M |
Net Income | $-36.12M | $-36.30M | $-78.28M | $-92.22M |
EPS (Diluted) | $-0.30 | $-0.31 | $-0.68 | $-0.83 |
Total Assets | $1.75B | $1.74B | $1.61B | $1.44B |
Total Liabilities | $1.42B | $1.34B | $1.26B | $1.17B |
Cash & Equivalents | $187.76M | $328.65M | $237.13M | $300.87M |
Free Cash Flow OCF − CapEx | $254.65M | $213.23M | $148.15M | $121.79M |
Shares Outstanding | 120.12M | 118.79M | 115.41M | 113.06M |